Pediatric obesity is a global health concern. Rates of obesity in pediatric populations remain high in developed countries such as the United States and Canada, with prevalence rates of 18.5% and 13.1%, respectively (1). This is of particular importance because of the association of pediatric obesity with metabolic syndrome, inflammation, and a variety of other comorbidities (2). Current weightmanagement treatments for pediatric patients include behavioral therapy, pharmacotherapy, and bariatric surgery (3). These treatments can help patients lose weight. However, there has been concern that, in children and adolescents, they may promote or worsen disordered eating behaviors, such as binge eating (BE) and loss of control eating (LOC) (4). Several mechanisms have been proposed that may underlie this relationship (5). High levels of rigid dietary restraint have been identified as a central risk and maintaining factor of BE. Dieting may result in hunger and associated physiological responses, which may contribute to BE. In some individuals, externally or self-imposed dietary rules may be strict and increasingly difficult to sustain over the long term. The inevitable breaking of these rules may induce an all-or-none reaction, resulting in BE (i.e., the abstinence violation effect).BE is reported by 20% to 35% of youth seeking weight loss (6). BE is defined as "the subjective experience of loss of control while eating a reportedly objectively large amount of food" (7).In 2013, the Diagnostic and Statistical Manual of Mental Disorders (Fifth Edition) added binge eating disorder (BED) as an independent diagnosis for those who have recurrent BE episodes while